Novation Pharmaceuticals Inc
Novation Pharmaceuticals Inc, located in Burnaby, British Columbia, is dedicated to developing innovative therapies targeting neurodegenerative diseases, with a primary focus on amyotrophic lateral sclerosis (ALS). The company employs its proprietary QUEST technology to identify small molecules that modulate intracellular mRNA, aiming to bring effective treatments quickly to market.
Founded in 2003, Novation collaborates with esteemed research institutions, including the University of Montreal, to advance its drug discovery initiatives. With a commitment to transforming ALS treatment options, Novation aims to build a product-focused business while generating early revenues through strategic partnerships with pharmaceutical companies.
Generated from the website
